Psychosis TMS Study
Psychosis
About this trial
This is an interventional basic science trial for Psychosis focused on measuring Cognitive impairment, Transcranial Magnetic Stimulation, Attention, Short-term memory
Eligibility Criteria
Inclusion Criteria: Diagnosis of psychosis, psychosis not otherwise specified, schizophrenia, schizoaffective disorder, delusional disorder, bipolar disorder with psychosis, and schizophreniform disorder within first ten years of onset of psychotic symptoms. Ability to provide informed consent Exclusion Criteria: TMS incompatibility including metallic implants in head and neck, cardiac pacemakers, history of seizures, pregnancy. MRI-incompatibility including implanted aneurism clips, cardiac pacemakers, metal implants, intrauterine devices, tattoos containing metal ink, pregnancy, and claustrophobia Severe substance abuse within 3 months (nicotine allowed) Unstable medical or neurologic illness that would preclude participation in study procedures
Sites / Locations
- Martinos Center for Biomedical ImagingRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Active TMS
Placebo TMS
Participants will receive single-session administration of TMS. Functional MRI will be acquired before and immediately after the intervention.
Participants will also receive single session administration of placebo TMS (at least two days apart from the day of the active TMS). Functional MRI will be acquired before and immediately after the intervention.